Revenue: $110 million in Q1 2025, a 1% sequential decline and a 10% year-over-year decline. Quarterly Paid Employers: 63,000, representing an 11% year-over-year decrease but a 10% sequential increase. Revenue per Paid Employer: $1,734, up 2% year over year and down 10% sequentially. Net Loss: $12.8 million in Q1 2025, compared to a net loss
First Quarter Consolidated Results Operating Revenues: Operating revenues were $745.8 million, up 9.7%. Organic operating revenue growth was 9.9%. The $65.9 million increase was the result of a $39.6 million increase in recurring subscription revenues and a $27.2 million increase in asset-based fees, partially offset by a $0.9 million decrease in non-recurring revenues. Run Rate
The segment’s operating and Adjusted EBITDA margin increases were primarily due to lower merchandise and production costs as a percentage of revenues. These were partially offset by higher healthcare claims expense and selling and administrative costs as a percentage of revenues in the second quarter of fiscal 2025. Specialty Garments Revenues for the quarter were $44.4
Revenue: $148 million, up 4% year-over-year on an organic basis. Non-GAAP EPS: $0.08 per share. Adjusted EBITDA Margin: 9%, representing a 400 basis point expansion year-over-year. Free Cash Flow: $2 million for the quarter. Cash Position: $530 million in cash, cash equivalents, and marketable securities. Sample Management Solutions Revenue: $81 million, up 3% year-over-year. Multiomics